SCHEMBL4407865

SCHEMBL4407865

Cc1nc2cc(CCC(N)=O)ccc2s1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.61
NPC1 O15118 6/20 0.54
RAB9A P51151 6/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
DYRK1A Q13627 1/20 0.49
MAPT P10636 2/20 0.48
HPGD P15428 2/20 0.48
NFKB1 P19838 2/20 0.48
NFKB2 Q00653 2/20 0.48
RELA Q04206 2/20 0.48
STAT1 P42224 1/20 0.48
ALDH1A1 P00352 2/20 0.45
LDHA P00338 2/20 0.43
TP53 P04637 2/20 0.42
PKM P14618 2/20 0.42
POLB P06746 1/20 0.42
CASP3 P42574 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
TRPV1 Q8NER1 1/20 0.41
P2RX3 P56373 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3813803 0.80 HSD17B10 (0.76) HSD17B10NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL8185281 0.79 HSD17B10 (0.68) HSD17B10NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL4407874 0.78 HSD17B10 (0.62) HSD17B10NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL7231445 0.78 HSD17B10 (0.67) HSD17B10NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL13156344 0.77 HSD17B10 (0.70) HSD17B10NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL3436150 0.77 HSD17B10 (1.00) HSD17B10NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL3817327 0.76 HSD17B10 (0.56) HSD17B10NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL2707387 0.75 LDHA (0.60) HSD17B10NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL464409 0.75 HSD17B10 (0.72) HSD17B10NPC1RAB9ASMN1; SMN2MAPT
SCHEMBL31359187 0.75 HSD17B10 (0.72) HSD17B10NPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009135526-A1 ALPHA-MERCAPTO-AMIDES NOVARTIS AG (CH) 2009-11-12 WO disclosed